[Federal Register Volume 61, Number 88 (Monday, May 6, 1996)]
[Notices]
[Pages 20275-20276]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11217]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Importation of Controlled Substances; Notice of Application
Pursuant to Section 1008 of the Controlled Substances Import and
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
regulation under Section 1002(a) authorizing the importation of such a
substance, provide manufacturers holding registrations for the bulk
manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Section 1311.42 of Title 21, Code of
Federal Regulations (CFR), notice is hereby given that on March 27,
1996, Research Biochemicals, Limited Partnership, Attn: Richard Milius,
1-3 Strathmore Road, Natick, Massachusetts 01760, made application to
the Drug Enforcement Administration to be registered as an importer of
the basic classes of controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methaqualone (2565)........................ I
Ibogaine (7260)............................ I
Tetrahydrocannabinols (7370)............... I
Bufotenine (7433).......................... I
Dimethyltryptamine (7435).................. I
Etorphine (except HCl) (9056).............. I
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Diprenorphine (9058)....................... II
Etorphine Hydrochloride (9059)............. II
Diphenoxylate (9170)....................... II
Metazocine (9240).......................... II
Methadone (9250)........................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to import small quantities of the controlled
substances to manufacture laboratory reference standards and
neurochemicals.
Any manufacturer holding, or applying for, registration as a bulk
manufacturer of these basic classes of
[[Page 20276]]
controlled substances may file written comments on or objections to the
application described above and may, at the same time, file a written
request for a hearing on such application in accordance with 21 CFR
1301.54 in such form as prescribed by 21 CFR 1316.47.
Any such comments, objections, or requests for a hearing may be
addressed, in quintuplicate, to the Deputy Assistant Administrator,
Office of Diversion Control, Drug Enforcement Administration, United
States Department of Justice, Washington, D.C. 20537, Attention: DEA
Federal Register Representative (CCR), and must be filed no later than
(30 days from publication).
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1311.42 (b), (c),
(d), (e), and (f). As noted in a previous notice at 40 FR 43745-46
(September 23, 1975), all applicants for registration to import basic
classes of any controlled substances in Schedule I or II are and will
continue to be required to demonstrate to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration that the requirements for such registration pursuant to
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c),
(d), (e), and (f) are satisfied.
Dated: April 30, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-11217 Filed 5-3-96; 8:45 am]
BILLING CODE 4410-09-M
